1. Antypa N, Souery D, Tomasini M, Albani D, Fusco F, Mendlewicz J, Serretti A. Clinical and genetic factors associated with suicide in mood disorder patients. Eur Arch Psychiatry Clin Neurosci 2016; 266: 181-193.
2.
Bhowmick R, Sarkar RR. Identification of potential microRNAs regulating metabolic plasticity and cellular phenotypes in glioblastoma. Mol Genet Genomics 2023; 298: 161-181.
3.
Camelo-Piragua S, Kesari S. Further understanding of the pathology of glioma: implications for the clinic. Expert Rev Neurother 2016; 16: 1055-1065.
4.
Cao S, Han X, Ding C, Wang S, Tian M, Wang X, Hou W, Yue J, Wang G, Yu S. Molecular cloning of the duck mitogen-activated protein kinase 1 (MAPK1) gene and the development of a quantitative real-time PCR assay to detect its expression. Poult Sci 2014; 93: 2158-2167.
5.
Chen R, Smith-Cohn M, Cohen AL, Colman H. Glioma subclassifications and their clinical significance. Neurotherapeutics 2017; 14: 284-297.
6.
Chen X, Chen J. miR-3188 regulates cell proliferation, apoptosis, and migration in breast cancer by targeting TUSC5 and regulating the p38 MAPK signaling pathway. Oncol Res 2018; 26: 363-372.
7.
Cheng Z, Shu H, Cui Y, Zhang Q, Zhao B, Pan D, Chao Q, Wang D. MiR-424-5p inhibits proliferation, invasion and promotes apoptosis and predicts good prognosis in glioma by directly targeting BFAR [Retracted article]. Pathol Oncol Res 2020; 26: 2327-2335.
8.
Ding HX, Lv Z, Yuan Y, Xu Q. MiRNA polymorphisms and cancer prognosis: A systematic review and meta-analysis. Front Oncol 2018; 8: 596.
9.
Irving EA, Barone FC, Reith AD, Hadingham SJ, Parsons AA. Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Brain Res Mol Brain Res 2000; 77: 65-75.
10.
Li N, Chen J, Zhao J, Wang T. MicroRNA-3188 targets ETS-domain protein 4 and participates in RhoA/ROCK pathway to regulate the development of atherosclerosis. Pharmazie 2017; 72: 687-693.
11.
Li Y, Chen X, Xue W, Liang J, Wang L. MiR-874 inhibits cell proliferation, migration, and invasion of glioma cells and correlates with prognosis of glioma patients. Neuromolecular Med 2021; 23: 247-255.
12.
Malta TM, de Souza CF, Sabedot TS, Silva TC, Mosella MS, Kalkanis SN, Snyder J, Castro AVB, Noushmehr H. Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications. Neuro Oncol 2018; 20: 608-620.
13.
Mao F, Wang B, Xiao Q, Cheng F, Lei T, Guo D. LRIG proteins in glioma: Functional roles, molecular mechanisms, and potential clinical implications. J Neurol Sci 2017; 383: 56-60.
14.
Rahman R. Toward the next generation of high-grade glioma clinical trials in the era of precision medicine. Cancer J 2021; 27: 410-415.
15.
Rios-Colon L, Deep G, Kumar D. Emerging role of microRNA 628-5p as a novel biomarker for cancer and other diseases. Tumour Biol 2019; 41: 1010428319881344.
16.
Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 2017; 16: 203-222.
17.
Shi HZ, Wang DN, Ma LN, Zhu H. MicroRNA-362 inhibits cell growth and metastasis in glioblastoma by targeting MAPK1. Eur Rev Med Pharmacol Sci 2020; 24: 8931-8939.
18.
Tom MC, Cahill DP, Buckner JC, Dietrich J, Parsons MW, Yu JS. Management for different glioma subtypes: are all low-grade gliomas created equal? Am Soc Clin Oncol Educ Book 2019; 39: 133-145.
19.
Xu J, Liu F, Xia Z, He K, Xiang G. MiR-3188 regulates the proliferation and apoptosis of hepatocellular carcinoma cells by targeting CXCL14. Biomark Med 2021; 15: 1611-1621.
20.
Xue WS, Wang N, Wang NY, Ying YF, Xu GH. miR-145 protects the function of neuronal stem cells through targeting MAPK pathway in the treatment of cerebral ischemic stroke rat. Brain Res Bull 2019; 144: 28-38.
21.
Yasinjan F, Xing Y, Geng H, Guo R, Yang L, Liu Z, Wang H. Immunotherapy: a promising approach for glioma treatment. Front Immunol 2023; 14: 1255611.
22.
Zhao H, Wang Y, Liang C, Xie M. LncRNA FOXD3-AS1/miR-128-3p axis-mediated IGF2BP3 in glioma stimulates cancer angiogenesis and progression. Folia Neuropathol 2023; 61: 168-184.
23.
Zhao M, Luo R, Liu Y, Gao L, Fu Z, Fu Q, Luo X, Chen Y, Deng X, Liang Z, Li X, Cheng C, Liu Z, Fang W. Author Correction: miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN. Nat Commun 2021; 12: 2997.
24.
Zhou B, Liu Y, Ma G, Wang X, Chang B, Lu H, Feng X. ADAMTS8 inhibits glioma development in vitro and in vivo. Folia Neuropathol 2023; 61: 144-152.
25.
Zhou S, Xia L, Chen Y, Guo W, Hu J. miR-3188 Regulates proliferation and apoptosis of granulosa cells by targeting KCNA5 in the polycystic ovary syndrome. Acta Biochim Pol 2021; 68: 83-89.
26.
Zhu L, Yang S, Wang J. miR-217 inhibits the migration and invasion of HeLa cells through modulating MAPK1. Int J Mol Med 2019; 44: 1824-1832.
27.
Ziogas IA, Sioutas G, Mylonas KS, Tsoulfas G. Role of microRNA in the diagnosis and management of hepatocellular carcinoma. Microrna 2020; 9: 25-40.
